• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Heart Failure Cases Split Evenly Between Reduced, Preserved Ejection Fraction

Publication
Article
MHE PublicationMHE January 2021
Volume 31
Issue 1

The prevalence of heart failure is increasing as the demographic profile of the American population gets older.

The prevalence of heart failure is increasing as the demographic profile of the American population gets older.

An estimated 6.2 million American adults, age 20 and older, had heart failure between 2013 and 2016, compared with an estimated 5.7 million between 2009 and 2012.

Of incident hospitalized heart failure events, approximately half are characterized by reduced ejection fraction and half by preserved ejection fraction.

The prevalence of heart failure with preserved ejection fraction, compared with prevalence of heart failure with reduced ejection fraction, appears to be increasing along with aging of the population.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.